Quick Answer
Evofem Biosciences, Inc. reported Total Assets of $23.79 million for fiscal year 2024.
Evofem Biosciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $23.79M | +125.4% |
| 2023 | $10.55M | -58.1% |
| 2022 | $25.16M | -40.8% |
| 2021 | $42.51M | -61.3% |
| 2020 | $109.97M | +288.6% |
| 2019 | $28.30M | +605.6% |
| 2018 | $4.01M | +1.5% |
| 2017 | $3.95M | -69.2% |
| 2016 | $12.82M | -68.0% |
| 2015 | $40.11M | -47.8% |
| 2014 | $76.90M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.81M | -42.3% | -4.0% |
| June 30, 2025 | $14.38M | +68.2% | +11.7% |
| March 31, 2025 | $12.88M | +56.7% | -45.9% |
| December 31, 2024 | $23.79M | +125.4% | -0.6% |
| September 30, 2024 | $23.94M | +79.7% | +180.0% |
| June 30, 2024 | $8.55M | -39.2% | +4.1% |
| March 31, 2024 | $8.22M | -68.4% | -22.1% |
| December 31, 2023 | $10.55M | -58.1% | -20.8% |
- Evofem Biosciences, Inc. showed an increase of +125.4% in Total Assets compared to the prior fiscal year.
- Over the 2014–2024 period, Evofem Biosciences, Inc.’s total assets has declined by 69.1% (from $76.90 million to $23.79 million).
- The most recent figure is from Evofem Biosciences, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: